Unknown

Dataset Information

0

Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism.


ABSTRACT: We present the largest exome sequencing study of autism spectrum disorder (ASD) to date (n = 35,584 total samples, 11,986 with ASD). Using an enhanced analytical framework to integrate de novo and case-control rare variation, we identify 102 risk genes at a false discovery rate of 0.1 or less. Of these genes, 49 show higher frequencies of disruptive de novo variants in individuals ascertained to have severe neurodevelopmental delay, whereas 53 show higher frequencies in individuals ascertained to have ASD; comparing ASD cases with mutations in these groups reveals phenotypic differences. Expressed early in brain development, most risk genes have roles in regulation of gene expression or neuronal communication (i.e., mutations effect neurodevelopmental and neurophysiological changes), and 13 fall within loci recurrently hit by copy number variants. In cells from the human cortex, expression of risk genes is enriched in excitatory and inhibitory neuronal lineages, consistent with multiple paths to an excitatory-inhibitory imbalance underlying ASD.

SUBMITTER: Satterstrom FK 

PROVIDER: S-EPMC7250485 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism.

Satterstrom F Kyle FK   Kosmicki Jack A JA   Wang Jiebiao J   Breen Michael S MS   De Rubeis Silvia S   An Joon-Yong JY   Peng Minshi M   Collins Ryan R   Grove Jakob J   Klei Lambertus L   Stevens Christine C   Reichert Jennifer J   Mulhern Maureen S MS   Artomov Mykyta M   Gerges Sherif S   Sheppard Brooke B   Xu Xinyi X   Bhaduri Aparna A   Norman Utku U   Brand Harrison H   Schwartz Grace G   Nguyen Rachel R   Guerrero Elizabeth E EE   Dias Caroline C   Betancur Catalina C   Cook Edwin H EH   Gallagher Louise L   Gill Michael M   Sutcliffe James S JS   Thurm Audrey A   Zwick Michael E ME   Børglum Anders D AD   State Matthew W MW   Cicek A Ercument AE   Talkowski Michael E ME   Cutler David J DJ   Devlin Bernie B   Sanders Stephan J SJ   Roeder Kathryn K   Daly Mark J MJ   Buxbaum Joseph D JD  

Cell 20200123 3


We present the largest exome sequencing study of autism spectrum disorder (ASD) to date (n = 35,584 total samples, 11,986 with ASD). Using an enhanced analytical framework to integrate de novo and case-control rare variation, we identify 102 risk genes at a false discovery rate of 0.1 or less. Of these genes, 49 show higher frequencies of disruptive de novo variants in individuals ascertained to have severe neurodevelopmental delay, whereas 53 show higher frequencies in individuals ascertained t  ...[more]

Similar Datasets

| S-EPMC4375789 | biostudies-literature
| S-EPMC6673916 | biostudies-literature
| S-EPMC4578871 | biostudies-literature
| S-EPMC3863639 | biostudies-literature
| S-EPMC10502753 | biostudies-literature
| S-EPMC3978951 | biostudies-literature
| S-EPMC8832975 | biostudies-literature
| S-EPMC5245907 | biostudies-literature
| S-EPMC5282828 | biostudies-literature
| S-EPMC6562004 | biostudies-literature